Standout Papers

The 2019 WHO classificatio... 2001 2026 2009 2017 2.2k
  1. The 2019 WHO classification of tumours of the digestive system (2019)
    Irıs D. Nagtegaal, Robert D. Odze et al. Histopathology
  2. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images (2019)
    Gabriele Campanella, Matthew G. Hanna et al. Nature Medicine
  3. DAXX / ATRX , MEN1 , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors (2011)
    Yuchen Jiao, Chanjuan Shi et al. Science
  4. Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry (2005)
    Ki Y. Chung, Jinru Shia et al. Journal of Clinical Oncology
  5. Pancreatic Intraepithelial Neoplasia (2001)
    Ralph H. Hruban, Volkan Adsay et al. The American Journal of Surgical Pathology
  6. The Pathologic Classification of Neuroendocrine Tumors (2010)
    David S. Klimstra, Domenico Coppola et al. Pancreas
  7. An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms (2004)
    Ralph H. Hruban, Kyoichi Takaori et al. The American Journal of Surgical Pathology
  8. Intrahepatic Cholangiocarcinoma (2008)
    Itaru Endo, Mithat Gönen et al. Annals of Surgery
  9. Long-Term Survival After Curative Resection for Pancreatic Ductal Adenocarcinoma (1996)
    Kevin C. Conlon, David S. Klimstra et al. Annals of Surgery
  10. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms (2022)
    Guido Rindi, Özgür Mete et al. Endocrine Pathology
  11. Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumors (2013)
    Pamela L. Kunz, Diane Reidy‐Lagunes et al. Pancreas
  12. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention (2018)
    Maeve A. Lowery, Ryan Ptashkin et al. Clinical Cancer Research
  13. The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms (2015)
    Olca Baştürk, Zhaohai Yang et al. The American Journal of Surgical Pathology
  14. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions (2017)
    Jaclyn F. Hechtman, Ryma Benayed et al. The American Journal of Surgical Pathology

Immediate Impact

4 by Nobel laureates 14 from Science/Nature 137 standout
Sub-graph 1 of 19

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
From patterns to patients: Advances in clinical machine learning for cancer diagnosis, prognosis, and treatment
2023 Standout
12 intermediate papers

Works of David S. Klimstra being referenced

Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies
2020
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
2019 Standout
and 24 more

Author Peers

Author Last Decade Papers Cites
David S. Klimstra 33496 18697 16137 486 47.2k
Michel Ducreux 25207 11207 7308 612 36.6k
Günter Klöppel 18600 12563 12151 448 29.0k
Aldo Scarpa 16876 5233 9091 597 32.1k
Christopher L. Wolfgang 21682 12339 7126 469 27.1k
Massimo Falconi 25843 13375 15679 647 30.6k
Michael A. Choti 16788 12183 5142 302 28.3k
Jaffer A. Ajani 16398 20687 3561 923 44.0k
Richard Kaplan 22048 7599 3809 171 45.0k
Yung‐Jue Bang 20426 7405 2734 602 36.1k
Larry Rubinstein 22032 7219 3665 195 46.6k

All Works

Loading papers...

Rankless by CCL
2026